HCA Healthcare's $1.73 Billion Volume Spike Pushes It to 120th in Market Activity Amid 223.52% Surge

On September 19, 2025, , . , reflecting heightened institutional interest amid strategic positioning in the healthcare sector.

Recent developments highlight HCA’s operational resilience as it navigates regulatory scrutiny and market dynamics. Analysts note that the company’s recent capital allocation decisions and debt restructuring efforts have stabilized investor sentiment. However, ongoing competition in the outpatient services segment remains a key risk factor, with market participants closely monitoring contract renegotiations with insurance providers.

To set up this back-test precisely, I need to confirm a few practical details: Universe—Are we looking at all U.S.–listed equities (NYSE + NASDAQ + AMEX), or a different market/universe? Trade timing & price type—Do we buy the selected stocks at that day’s close and sell at the next day’s close (Close-to-Close), or buy next day’s open and sell at that day’s close (Close-to-Open)? Weighting—Should the 500 names be equally weighted, or sized by some factor (e.g., proportional to their dollar volume)? / slippage—Do you want to embed any commission, bid-ask spread, or other trading cost assumptions? Risk controls—Should we impose any stop-loss, take-profit, or maximum holding-period overrides beyond the 1-day rule? Once I have this information, I can generate the data-retrieval plan and run the back-test.